Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Intangibles (2016 - 2025)

Avanos Medical (AVNS) has disclosed Intangibles for 13 consecutive years, with $117.8 million as the latest value for Q4 2025.

  • Quarterly Intangibles rose 4.9% to $117.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $117.8 million through Dec 2025, up 4.9% year-over-year, with the annual reading at $117.8 million for FY2025, 4.9% up from the prior year.
  • Intangibles hit $117.8 million in Q4 2025 for Avanos Medical, down from $122.0 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $271.1 million in Q1 2022 to a low of $105.4 million in Q2 2025.
  • Historically, Intangibles has averaged $190.6 million across 5 years, with a median of $221.4 million in 2023.
  • Biggest five-year swings in Intangibles: skyrocketed 78.05% in 2022 and later crashed 53.95% in 2025.
  • Year by year, Intangibles stood at $141.2 million in 2021, then soared by 65.86% to $234.2 million in 2022, then increased by 2.26% to $239.5 million in 2023, then tumbled by 53.11% to $112.3 million in 2024, then increased by 4.9% to $117.8 million in 2025.
  • Business Quant data shows Intangibles for AVNS at $117.8 million in Q4 2025, $122.0 million in Q3 2025, and $105.4 million in Q2 2025.